美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Endovia Health Sciences Inc

0.1460

-0.0100-6.41%

盘前：0.1443-0.0017-1.16%05:54 EDT

成交量：28.73万

成交额：4.22万

市值：161.76万

市盈率：-0.01

高：0.1512

开：0.1500

低：0.1400

收：0.1560

52周最高：13.40

52周最低：0.1400

股本：1,107.93万

流通股本：1,107.14万

量比：0.13

换手率：2.59%

股息：- -

股息率：- -

每股收益(TTM):-13.6011

每股收益(LYR):-70.9984

净资产收益率：--

总资产收益率：-77.70%

市净率：-0.10

市盈率(LYR):0.00

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Endovia与Lupvindol Biosciences宣布FDA认定Cannepil®用于犬类骨癌疼痛属于小众用途，确立有条件批准路径资格

Endovia Health Sciences：FDA进一步裁定，将通过批准相关新兽药申请维持小众用途地位

Endovia Health Sciences于2026年9月18日与C/M Capital Master Fund签订意向书——SEC文件披露

Endovia Health Sciences 正积极评估更多大麻素配方及知识产权，寻求许可、收购与合作机会——SEC文件披露

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/EDVA"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EDVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","market":"US","secType":"STK","nameCN":"Endovia Health Sciences Inc","latestPrice":0.146,"timestamp":1791835200000,"preClose":0.156,"halted":0,"volume":287262,"hourTrading":{"tag":"盘前","latestPrice":0.1443,"preClose":0.146,"latestTime":"05:54 EDT","volume":5506,"amount":785.8317368,"timestamp":1791885274586,"change":-0.0017,"changeRate":-0.011644,"amplitude":0.041096},"delay":0,"changeRate":-0.06410256410256417,"floatShares":11071400,"shares":11079300,"eps":-13.601116,"marketStatus":"盘前交易","change":-0.01,"latestTime":"10-13 06:01:55 EDT","open":0.15,"high":0.1512,"low":0.14,"amount":42159.340982,"amplitude":0.071795,"askPrice":0.1789,"askSize":1749,"bidPrice":0.1401,"bidSize":264,"shortable":0,"etf":0,"ttmEps":-13.601116,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"exchange":"AMEX","adjPreClose":0.146,"preHourTrading":{"tag":"盘前","latestPrice":0.1443,"preClose":0.146,"latestTime":"05:54 EDT","volume":5506,"amount":785.8317368,"timestamp":1791885274586,"change":-0.0017,"changeRate":-0.011644,"amplitude":0.041096},"postHourTrading":{"tag":"盘后","latestPrice":0.1429,"preClose":0.146,"latestTime":"19:35 EDT","volume":1017,"amount":146.135984,"timestamp":1791848153785,"change":-0.0031,"changeRate":-0.021233,"amplitude":0.023973},"volumeRatio":0.13485829275278782},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","floatShares":11071400,"roa":"-77.70%","roe":"--","lyrEps":-70.998368,"volumeRatio":0.13485829275278782,"shares":11079300,"dividePrice":0,"high":0.1512,"amplitude":0.071795,"preClose":0.156,"low":0.14,"week52Low":0.14,"pbRate":"-0.10","psRate":"50.41","week52High":13.3996,"institutionHeld":0,"latestPrice":0.146,"committee":-0.737705,"eps":-13.601116,"divideRate":0,"volume":287262,"delay":0,"ttmEps":-13.601116,"open":0.15,"prevYearClose":2.7616,"prevWeekClose":0.156,"prevMonthClose":0.1757,"prevQuarterClose":0.1757,"fiveDayClose":0.1659,"twentyDayClose":0.2401,"sixtyDayClose":0.3744},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"EDVA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1787112000000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EDVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EDVA","date":"2026-10-12","current":-0.010734,"percent":1,"low":-0.155169,"twenty":-0.103616,"median":-0.090033,"eighty":-0.064034,"high":-0.057882,"avg":-0.088808,"sd":0.024303,"marketCap":1000353},"quantilePoints":[{"date":"2026-08-28","current":-0.118733,"twenty":-0.145082,"median":-0.136894,"eighty":-0.128751,"marketCap":2052006},{"date":"2026-09-04","current":-0.099624,"twenty":-0.136601,"median":-0.114948,"eighty":-0.105613,"marketCap":1721761},{"date":"2026-09-11","current":-0.090534,"twenty":-0.128751,"median":-0.109605,"eighty":-0.095565,"marketCap":1564655},{"date":"2026-09-18","current":-0.098697,"twenty":-0.117219,"median":-0.098326,"eighty":-0.091083,"marketCap":1705730},{"date":"2026-09-25","current":-0.070349,"twenty":-0.11379,"median":-0.094615,"eighty":-0.089265,"marketCap":1215813},{"date":"2026-10-02","current":-0.059737,"twenty":-0.111074,"median":-0.09161,"eighty":-0.073206,"marketCap":1032415},{"date":"2026-10-09","current":-0.059329,"twenty":-0.105613,"median":-0.090534,"eighty":-0.065311,"marketCap":1025362},{"date":"2026-10-12","current":-0.057882,"twenty":-0.103616,"median":-0.090033,"eighty":-0.064034,"marketCap":1000353}],"updateTime":1791885715482},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EDVA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161492507","title":"Endovia与Lupvindol Biosciences宣布FDA认定Cannepil®用于犬类骨癌疼痛属于小众用途，确立有条件批准路径资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1161492507","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161492507?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 20:46","pubTimestamp":1791204369,"startTime":"0","endTime":"0","summary":"Endovia与Lupvindol Biosciences宣布FDA认定Cannepil®用于犬类骨癌疼痛属于小众用途，确立有条件批准路径资格","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126910891","title":"Endovia Health Sciences：FDA进一步裁定，将通过批准相关新兽药申请维持小众用途地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1126910891","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126910891?lang=zh_cn&edition=fundamental","pubTime":"2026-10-05 20:46","pubTimestamp":1791204368,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences：FDA进一步裁定，将通过批准相关新兽药申请维持小众用途地位","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185625426","title":"Endovia Health Sciences于2026年9月18日与C/M Capital Master Fund签订意向书——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1185625426","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185625426?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 04:13","pubTimestamp":1790280789,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences Inc（EDVA）于2026年9月18日与C/M Capital Master Fund签署了一份意向书。根据SEC文件披露，该协议已于当日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135679679","title":"Endovia Health Sciences 正积极评估更多大麻素配方及知识产权，寻求许可、收购与合作机会——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1135679679","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135679679?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 04:11","pubTimestamp":1788207070,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新提交的文件，Endovia Health Sciences公司（股票代码：EDVA）目前不仅在推进现有业务，同时还在积极审视一系列额外的大麻素（cannabinoid）制剂及相关知识产权资产。这些评估涵盖多个维度，包括对外授权许可、潜在收购，以及战略合作等多元路径。该公司正以开放的姿态，探索多种可能性，以拓展其在这一领域的布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA","BK4169"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EDVA\",params:#limit:6,delay:false,,,undefined,":[]}}